Looping

Looping refers to an open and transparent effort to make safe and effective basic closed loop technology widely available to reduce the burden of Type 1 diabetes.

DIY Looping: Members in our diabetes community (Type 1Ds and parents of Type 1Ds) are not willing to wait for an approved solution and instead are using Loop. The system is not something that you can purchase from a manufacturer but a system that requires work to install, support to use and equipment to purchase. If you want a perfect system, this is not for you.

Learn more about Looping here from those in the community who are already running their own loop … and check out these resources, for more knowledge.

 

Savvy Updates 5/20/24: Twiist Insulin Pump, FDA Alerts on Chinese Syringe Imports, Playing Sports Lowers Insulin Resistance, Insulin Sensitizers, Dr. Rayhan Lal on Automated Insulin Delivery Systems, ADA Lists Best Hospitals for T1Ds (ONLY 17 in the US!), CGMs & Insulin Pumps for T2D Market, Black Basta Cyberattacks on Healthcare Systems, Prior Auths Need to be Fixed

Savvy Updates 5/20/24: Twiist Insulin Pump, FDA Alerts on Chinese Syringe Imports, Playing Sports Lowers Insulin Resistance, Insulin Sensitizers, Dr. Rayhan Lal on Automated Insulin Delivery Systems, ADA Lists Best Hospitals for T1Ds (ONLY 17 in the US!), CGMs & Insulin Pumps for T2D Market, Black Basta Cyberattacks on Healthcare Systems, Prior Auths Need to be Fixed

Meet the newest insulin pump: all about “twiist” with Sequel CEO Alan Lotvin by Stacey Simms for Diabetes-Connections.com, 16 April 2024. This week, the newest pump coming to the market is called the twiist. It’s a very different shape – circular with a top half that...

read more
Savvy Updates, 10/2/23: Senseonics Completes 365-Day Study, SiBionics CGM & GiveAway, Abvance’s  Coformulation of Insulin & Glucagon, Period Cravings & Insulin Sensitivies, Ozempic Reduces Insulin Needs in T1Ds, CVS Caremark Sued By Independent Pharmacy for Antitrust Violations

Savvy Updates, 10/2/23: Senseonics Completes 365-Day Study, SiBionics CGM & GiveAway, Abvance’s Coformulation of Insulin & Glucagon, Period Cravings & Insulin Sensitivies, Ozempic Reduces Insulin Needs in T1Ds, CVS Caremark Sued By Independent Pharmacy for Antitrust Violations

Senseonics completes 365-day CGM study cohort by Sean Whooley for DrugDeliveryBusiness.com, 26 September 2023. Senseonics announced that it completed its ENHANCE pivotal clinical study adult cohort for its 365-day Eversense CGM.  The study evaluates the year-long...

read more
Savvy Updates 9/5/23: InsuletGets TRO Against EOFlow, Beta Bionics Raises $100M, Research Grant for Liver Targeted Insulin, History/Future or DIY “Bionic Pancreas”, 1st Ten Drugs for Medicare Price Negoation, WellDoc’s Blue Star Gets FDA Clearance, Men & Women Differ in Cardiac Arrest Symptoms, CGM Companies Go Mainstream

Savvy Updates 9/5/23: InsuletGets TRO Against EOFlow, Beta Bionics Raises $100M, Research Grant for Liver Targeted Insulin, History/Future or DIY “Bionic Pancreas”, 1st Ten Drugs for Medicare Price Negoation, WellDoc’s Blue Star Gets FDA Clearance, Men & Women Differ in Cardiac Arrest Symptoms, CGM Companies Go Mainstream

Insulet gains amid winning TRO in dispute with EOFlow, CEO insider buy by Joshua Fineman for SeekingAlpha.com, 30 August 2023.   Insulet rose 8.1% at least partly after the insulin pump maker was granted a temporary restraining order in a trade secrets case...

read more
Savvy Update 7/31/23: SiBio Ketone Monitor, Time in Range (or TTIR), User Reviews (iLet, Dexcom G7), Aging & T1DD (EDIC), Report Device Issues to FDA, 9 Genes that Cause T1D, Strawberries & Health, More TCOYD Videos

Savvy Update 7/31/23: SiBio Ketone Monitor, Time in Range (or TTIR), User Reviews (iLet, Dexcom G7), Aging & T1DD (EDIC), Report Device Issues to FDA, 9 Genes that Cause T1D, Strawberries & Health, More TCOYD Videos

Continuous Ketone Monitoring – a world’s first from SiBio? by Tim Street for Diabettech.com, 17 July 2023.   SiBio describes itself as “an innovative company with medical active implant and medical artificial intelligence research and development as its core...

read more
Savvy Updates 1/16/23: CGM $$$, Insulin Pill Fails, Med School & AI, DIY Loop 3.0, 5-Minute Walks, T1D Kids & School Days

Savvy Updates 1/16/23: CGM $$$, Insulin Pill Fails, Med School & AI, DIY Loop 3.0, 5-Minute Walks, T1D Kids & School Days

CGM is BIG MONEY!!! How Abbott plans to make its Freestyle Libre a $10B product by Elise Reuter for MedTechDive.com, 10 January 2023.  CEO Robert Ford discussed plans to grow the market for Abbott’s continuous glucose monitors and its broader diabetes...

read more
Share This
Skip to content